Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Cells|July 26, 2024
Genetic Deficiencies of Hyaluronan DegradationStephen P Fink, Barbara Triggs-RaineOncogene|March 6, 2003
TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell linesStephen P Fink, Debra Mikkola, James K V Willson, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|September 18, 2023
Enzymatic Resolution and Decarboxylative Functionalization of α-Sulfinyl EstersSuraksha Gahalawat, Yesu Addepalli, Stephen P Fink, et al.Oncogene|December 8, 2004
Colon cancer secreted protein-2 (CCSP-2), a novel candidate serological marker of colon neoplasiaBaozhong Xin, Petra Platzer, Stephen P Fink, et al.Cancer Research|August 5, 2008
Ugene, a newly identified protein that is commonly overexpressed in cancer and binds uracil DNA glycosylaseChunguang Guo, Xiaodong Zhang, Stephen P Fink, et al.Plos One|May 30, 2013
Genetic variation in 15-hydroxyprostaglandin dehydrogenase and colon cancer susceptibilityCheryl L Thompson, Stephen P Fink, James D Lutterbaugh, et al.Nature Communications|February 11, 2023
Small molecule inhibitors of 15-PGDH exploit a physiologic induced-fit closing systemWei Huang, Hongyun Li, Janna Kiselar, et al.Digestive Diseases and Sciences|April 30, 2013
Colonic 15-PGDH levels are stable across distance and time and are not perturbed by aspirin interventionStephen P Fink, Dong-Hoon Yang, Jill S Barnholtz-Sloan, et al.Science Translational Medicine|April 25, 2014
Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD)Stephen P Fink, Mai Yamauchi, Reiko Nishihara, et al.Carcinogenesis|December 16, 2014
Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDsStephen P Fink, Dawn M Dawson, Yongyou Zhang, et al.Pageof 2